Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

被引：0
|
作者：
Takashi Seto
Naoyuki Nogami
Nobuyuki Yamamoto
Shinji Atagi
Naoki Tashiro
Yoko Yoshimura
Yutaka Yabuki
Hideo Saka
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] National Hospital Organization Shikoku Cancer Center,Department of Thoracic Oncology and Medicine
[3] Wakayama Medical University Hospital,Third Department of Internal Medicine
[4] National Hospital Organization Kinki-chuo Chest Medical Center,Department of Thoracic Oncology
[5] AstraZeneca K.K.,Medical Department
[6] National Hospital Organization Nagoya Medical Center,Department of Medical Oncology
来源：
Oncology and Therapy | 2018年 / 6卷 / 2期
关键词：
T790M; Epidermal growth factor receptor; Non-small-cell lung cancer; Osimertinib; Rebiopsy;
D O I：
10.1007/s40487-018-0064-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：203 / 215
页数：12
相关论文
共 50 条
  • [21] Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Kaji, Reiko
    Fujita, Shiro
    Imai, Yukihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E27 - E29
  • [22] ASTRIS: A multicenter, real world treatment study of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC)
    Cheema, P. K.
    Chen, Y-M.
    de Marinis, F.
    Freitas, H. C.
    Kim, S-W.
    Milner, A.
    Provencio, M.
    Rigas, J.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Therapeutic approaches for T790M mutation positive non-small-cell lung cancer
    Attili, Ilaria
    Karachaliou, Niki
    Conte, PierFranco
    Bonanno, Laura
    Rosell, Rafael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 1021 - 1030
  • [24] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
    Yu, Xiaoqing
    Si, Jinfei
    Wei, Jingwen
    Wang, Yanling
    Sun, Yan
    Jin, Jianan
    Zhang, Xiaoyan
    Ma, Tonghui
    Song, Zhengbo
    CANCER MEDICINE, 2023, 12 (05): : 5630 - 5638
  • [25] A PROSPECTIVE OBSERVATIONAL STUDY FOR MONITORING EGFR T790M USING PLASMA DNA IN LUNG CANCER PATIENTS
    Iwanaga, Kentaro
    Aragane, Naoko
    Katakami, Nobuyuki
    Satouchi, Miyako
    Yokota, Soichiro
    Aoe, Keisuke
    Otsuka, Kojiro
    Kimura, Shinya
    Negoro, Shunichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study
    Sueoka-Aragane, Naoko
    Katakami, Nobuyuki
    Satouchi, Miyako
    Yokota, Soichiro
    Aoe, Keisuke
    Iwanaga, Kentaro
    Otsuka, Kojiro
    Morita, Satoshi
    Kimura, Shinya
    Negoro, Shunichi
    CANCER SCIENCE, 2016, 107 (02) : 162 - 167
  • [27] High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer
    Ariyasu, Ryo
    Nishikawa, Shingo
    Uchibori, Ken
    Oh-hara, Tomoko
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Inase, Naohiko
    Kasahara, Kazuo
    Nishio, Makoto
    Katayama, Ryohei
    LUNG CANCER, 2018, 117 : 1 - 6
  • [28] Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer
    Singh, Pankaj Kumar
    Silakari, Om
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (05) : 469 - 483
  • [29] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
    De Marinis, Filippo
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Hochmair, Maximilian J.
    Metro, Giulio
    Vansteenkiste, Johan F.
    Vicente, David
    Solomon, Benjamin J.
    Cheema, Parneet K.
    Freitas, Helano C.
    Provencio, Mariano
    Chen, Yuh-Min
    Wu, Yi-Long
    Milner, Alvin
    Rigas, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Sequential treatment of afatinib followed by osimertinib in T790M EGFR mutation positive non-small-cell lung cancer (NSCLC) pa tients: an observational study
    Hochmair, M.
    Morabito, A.
    Hao, D.
    Yang, C. -T.
    Soo, R. A.
    Gucalp, R.
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    Cufer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 75 - 75
12345